Back

Drug-coated balloon versus drug-eluting stent revascularization in the treatment of de novo acute myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute myocardial infarction: innovative approaches to management and prediction Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ae-Young Her

Kangwon National University School of Medicine, Chuncheon (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Microdosing of alteplase leads to thrombolysis in an in vitro flow model of cardiac microvascular obstruction
Doctor A. Milusev (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Association between clinical ischemic risk and thrombogenicity phenotype and their prognostic prediction in patients undergoing percutaneous coronary intervention
Doctor D. Ohn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of stress hyperglycemia ratio on periprocedural myocardial infarction in patients with NSTEMI
Doctor C. Asta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Supersaturated oxygen therapy in patients with acute anterior myocardial infarction reduces infarct size
Professor A. Schaefer (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Platelet-large cell ratio predicts no-reflow in patients undergoing primary coronary angioplasty for ST-segment elevation myocardial infarction
Professor A. Scridon (Targu Mures, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Acute myocardial infarction: innovative approaches to management and prediction

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent for de novo culprit lesion in acute coronary syndromes: a report from nationwide registry in japan
thumbnail
Congress Presentation
Drug coated balloons-based approach versus conventional percutaneous coronary intervention with drug eluting stents for left anterior descending revascularization
thumbnail
Congress Presentation
Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources